MADISON, N.J., Sept. 11, 2015 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Thursday, September 17, 2015 at 11:10 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site:
https://cc.talkpoint.com/morg007/091615a_ae/?entity=152_0DTIKW8 and to the public on www.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 17, 2015.
About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Contacts: Dan Haemmerle (Investors): 973-520-2900 Dennis Moynihan (Media): 973-520-2800
SOURCE Quest Diagnostics